26 related articles for article (PubMed ID: 11857493)
1. Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells.
Yutori H; Semba S; Komori T; Yokozaki H
Cancer Sci; 2008 Mar; 99(3):524-30. PubMed ID: 18167129
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of the FHIT transcripts in osteosarcoma and Ewing sarcoma.
Hinohara S; Satake N; Sekine K; Kaneko Y
Jpn J Cancer Res; 1998 Sep; 89(9):887-94. PubMed ID: 9818023
[TBL] [Abstract][Full Text] [Related]
3. Significance and implications of FHIT gene expression and promoter hypermethylation in acute lymphoblastic leukemia (ALL).
Mohammad F; Pandith AA; Rasool SUA; Guru FR; Qasim I; Geelani S; Nisar S; Baba SM; Ganie FA; Kouser S; Rasool J
Discov Oncol; 2024 Apr; 15(1):108. PubMed ID: 38587694
[TBL] [Abstract][Full Text] [Related]
4. Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.
Chou CH; Hsieh MJ; Chuang CY; Lin JT; Yeh CM; Tseng PY; Yang SF; Chen MK; Lin CW
Oncotarget; 2017 Nov; 8(56):96225-96238. PubMed ID: 29221201
[TBL] [Abstract][Full Text] [Related]
5. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic mechanisms in oral carcinogenesis.
Gasche JA; Goel A
Future Oncol; 2012 Nov; 8(11):1407-25. PubMed ID: 23148615
[TBL] [Abstract][Full Text] [Related]
7. Relationship between abnormality of FHIT gene and EBV infection in gastric cancer.
Xiao YP; Han CB; Mao XY; Li JY; Xu L; Ren CS; Xin Y
World J Gastroenterol; 2005 Jun; 11(21):3212-6. PubMed ID: 15929169
[TBL] [Abstract][Full Text] [Related]
8. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
Dhillon VS; Shahid M; Husain SA
Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
[TBL] [Abstract][Full Text] [Related]
9. Alterations of common chromosome fragile sites in hematopoietic malignancies.
Ishii H; Furukawa Y
Int J Hematol; 2004 Apr; 79(3):238-42. PubMed ID: 15168591
[TBL] [Abstract][Full Text] [Related]
10. Cancer and the FRA3B/FHIT fragile locus: it's a HIT.
Huebner K; Croce CM
Br J Cancer; 2003 May; 88(10):1501-6. PubMed ID: 12771912
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
12. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
[TBL] [Abstract][Full Text] [Related]
13. Histones and long non-coding RNAs: the new insights of epigenetic deregulation involved in oral cancer.
González-Ramírez I; Soto-Reyes E; Sánchez-Pérez Y; Herrera LA; García-Cuellar C
Oral Oncol; 2014 Aug; 50(8):691-5. PubMed ID: 24844984
[TBL] [Abstract][Full Text] [Related]
14. Multiple molecular alterations of FHIT in betel-associated oral carcinoma.
Chang KW; Kao SY; Tzeng RJ; Liu CJ; Cheng AJ; Yang SC; Wong YK; Lin SC
J Pathol; 2002 Mar; 196(3):300-6. PubMed ID: 11857493
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of the FHIT gene in human oral carcinogenesis.
Tanimoto K; Hayashi S; Tsuchiya E; Tokuchi Y; Kobayashi Y; Yoshiga K; Okui T; Kobayashi M; Ichikawa T
Br J Cancer; 2000 Feb; 82(4):838-43. PubMed ID: 10732756
[TBL] [Abstract][Full Text] [Related]
16. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
